CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-15 | Levinson Mitchell E. Chief Strategy Officer | Purchase | +2,300 | $5.94 | $14K | 3,234 |
| 2023-11-15 | Levinson Mitchell E. Chief Strategy Officer | Purchase | +100 | $5.94 | $594 | 834 |
| 2023-11-15 | Levinson Mitchell E. Chief Strategy Officer | Purchase | +2,400 | $5.85 | $14K | 3,234 |
| 2023-11-15 | Levinson Mitchell E. Chief Strategy Officer | Purchase | +100 | $5.90 | $590 | 834 |
| 2023-11-15 | Levinson Mitchell E. Chief Strategy Officer | Purchase | +2,400 | $5.80 | $14K | 3,234 |
| 2023-11-15 | Levinson Mitchell E. Chief Strategy Officer | Purchase | +1,039 | $6.13 | $6K | 1,039 |
| 2023-11-13 | Zanganeh Mahkam Director | Option exercise | +20,000 | $2.14 | $43K | 548,836 |
| 2023-11-13 | Zanganeh Mahkam Director | Option exercise | +56,075 | $2.14 | $120K | 604,911 |
| 2023-11-13 | Zanganeh Mahkam Director | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2023-11-13 | Zanganeh Mahkam Director | Option exercise · Stock Option (right to buy) | −56,075 | 0 | ||
| 2023-11-07 | DUGGAN ROBERT W Director | Option exercise | +3,333 | $5.95 | $20K | 36,236,624 |
| 2023-11-07 | DUGGAN ROBERT W Director | Option exercise | +9,932 | $5.95 | $59K | 36,246,556 |
| 2023-11-07 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −3,333 | 11,667 | ||
| 2023-11-07 | DUGGAN ROBERT W Director | Option exercise · Stock Option (right to buy) | −9,932 | 29,799 | ||
| 2023-11-01 | Danahy Kevin Patrick Chief Executive Officer | Other disposition · Stock Option (right to buy) | −130,000 | 0 | ||
| 2023-11-01 | Danahy Kevin Patrick Chief Executive Officer | Grant or award · Stock Option (right to buy) | +460,000 | 460,000 | ||
| 2023-11-01 | UECKER DARRIN Chief Technology Officer | Grant or award · Stock Option (right to buy) | +330,000 | 330,000 | ||
| 2023-11-01 | Levinson Mitchell E. Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-10-23 | Danahy Kevin Patrick Chief Executive Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2023-08-25 | DUGGAN ROBERT W Director | Option exercise | +1,667 | $5.95 | $10K | 36,233,291 |
Page 11 of 15 · 292 trades